Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
---|---|---|---|---|---|---|
2015 | Effect modifying role of serum calcium on mortality-predictability of PTH and alkaline phosphatase in hemodialysis patients: An investigation using data from the Taiwan Renal Registry Data System from 2005 to 2012 | Lin Y.-C.; Lin Y.-C.; Hsu C.-Y.; Kao C.-C.; FAN-CHI CHANG ; Chen T.-W.; Chen H.-H.; Hsu C.-C.; Wu M.-S.; Chen H.-C.; Lin Y.-F.; Chen H.-H.; Yang W.-C.; Yang C.-W.; Wu C.-J.; Wu M.-J.; KWAN-DUN WU ; Lin Y.-H.; Li S.-H.; KUAN-YU HUNG ; Tarng D.-C.; Shu K.-H.; Chang H.-R.; Chen G.-S.; Chen J.-B.; Hwang S.-J.; Yang M.-J.; Cheng C.-H.; Lu K.-C.; Huang C.-C.; Ng Y.-Y.; Lee C.-T.; Sung J.-M.; Jong-Da L.; Ferng S.-H.; Tsai J.-C. | PLoS ONE | 19 | 7 | |
2013 | In acute kidney injury, indoxyl sulfate impairs human endothelial progenitor cells: Modulation by statin | VIN-CENT WU ; Young G.-H.; Huang P.-H.; SHYH-CHYI LO ; KUOCHUAN WANG ; Sun C.-Y.; Liang C.-J.; TAO-MIN HUANG ; Chang F.-C.; FAN-CHI CHANG ; YUH-LIEN CHEN ; Kuo Y.-S.; Chen J.-B.; Chen J.-W.; YUNG-MING CHEN ; Ko W.-J.; KWAN-DUN WU | Angiogenesis | 76 | 71 | |
2011 | A new drug design targeting the adenosinergic system for huntington's disease | Huang N.-K.; Lin J.-H.; Lin J.-T.; Lin C.-I.; Liu E.M.; CHUN-JUNG LIN ; Chen W.-P.; Shen Y.-C.; Chen H.-M.; Chen J.-B.; Lai H.-L.; Yang C.-W.; Chiang M.-C.; Wu Y.-S.; Chang C.; Chen J.-F.; Fang J.-M.; Lin Y.-L.; Chern Y. | PLoS ONE | 72 | 63 | |
2018 | Norepinephrine Administration Is Associated with Higher Mortality in Dialysis Requiring Acute Kidney Injury Patients with Septic Shock | Chen, Ying-Ying; VIN-CENT WU ; Huang, Wei-Chieh; YU-CHANG YEH ; Wu, Mai-Szu; Huang, Chiu-Ching; Wu, Kwan-Dun; Fang, Ji-Tseng; Wu, Chih-Jen; SHUEI-LIONG LIN ; TAI-SHUAN LAI ; YU-FENG LIN ; I-JUNG TSAI ; CHUN-FU LAI ; TAO-MIN HUANG ; Chu T.-S.; YUNG-MING CHEN ; Chang Y.-H.; Yeh Y.-C.; Lai C.-H.; Tseng L.-J.; KWAN-DUN WU ; Wang J.-J.; Chen C.-Y.; Shiao C.-C.; Wang W.-J.; Lin J.-H.; Wu C.-H.; Wu C.-J.; Lu K.-C.; Kan W.-C.; Huang C.-C.; Chou C.-Y.; Yang Y.-F.; Tsai J.-P.; Hu F.-C.; Lee C.-T.; Chen J.-B.; Lee C.-H.; Lee W.-C.; Li L.-C.; Chen T.-C.; Lin H.Y.-H.; Chen Y.-C.; Lee C.-C.; Sun C.-Y.; Pan H.-C.; Chang M.-Y.; Jenq C.-C.; Lin C.-Y.; Chang C.-H.; Tsai T.-Y.; Chen C.-M.; Lin E.-T.; Wu C.-J.; Lin C.-J.; Wu P.-C.; Kuo F.-C.; Weng C.-J.; Chen L.-K.; Lin S.-L.; Yang W.-S.; Hsu W.-D.; Leu J.-G.; Chang J.-T.; Liou H.-H.; Hsu K.-H.; Wu M.-J.; Huang C.-T.; You Z.-H.; Chang C.-F.; Chen T.-W.; Chen H.-H.; FAN-CHI CHANG ; Lin Y.-C.; Wu M.-S.; Kao C.-C.; Hung S.-C.; Kuo K.-L.; Wu C.-H.; Tarng D.-C.; Chen J.-Y.; Yang C.-Y.; Lee K.-H.; Ko S.-W.; The NSARF, CAKS Group | Journal of clinical medicine | 13 | 10 | |
2012 | The pharmacological mechanisms of omalizumab in patients with very high IgE levels - Clues from studies on atopic dermatitis | Chang T.W.; Chen J.-B.; CHIA-YU CHU | Dermatologica Sinica | 14 | 15 | |
2010 | Unique epitopes on CεmX in IgE-B cell receptors are potentially applicable for targeting IgE-committed B cells | Chen J.-B.; Wu P.C.; Hung A.F.-H.; CHIA-YU CHU ; TSEN-FANG TSAI ; Yu H.-M.; Chang H.-Y.; Chang T.W. | Journal of Immunology | 39 | 37 |